The following is Bayer’s statement regarding an order by Judge Vince Chhabria in the District Court for the Northern District of California vacating the upcoming May 20, 2019 trial date for Stevick v. Monsanto and ordering mediation in the California MDL. “We will of course comply with the Court’s mediation order in good faith. As […]
Bayer released the following statement regarding the release of a draft toxicological profile for glyphosate by the Agency for Toxic Substances and and Disease Registry (ATSDR). “We welcome this scientific review of glyphosate, the active ingredient in many of our Roundup-branded products. It is important to recognize that this is a review of the existing […]
Bayer released the following statement regarding the Superior Court of the State of California’s ruling to tentatively deny plaintiffs’ request for a temporary restraining order on alleged company advertising. “Bayer is pleased that that Court has tentatively denied plaintiffs’ request for a temporary restraining order on company advertising which has no basis in law, while […]
The following is Bayer’s statement regarding the commencement of the Pilliod glyphosate-based herbicide trial before Judge Winifred Smith in the Superior Court of the State of California for the County of Alameda. This is the first case in the glyphosate JCCP coordinated proceeding to go to trial. “While we have great sympathy for the plaintiffs, […]
Bayer released the following statement in reaction to the phase two verdict in favor of the plaintiff in the case of Hardeman v Monsanto, a trial conducted in the federal glyphosate multi-district litigation before Judge Vince Chhabria in the Northern District of California. “We are disappointed with the jury’s decision, but this verdict does not change […]
Bayer released the following statement in reaction to a phase one verdict in favor of the plaintiff in the case of Hardeman v Monsanto, a trial conducted in the federal glyphosate multi-district litigation before Judge Vince Chhabria in the Northern District of California. The jury reached a decision in this first phase on causation, but […]
The following is Bayer’s statement regarding the commencement of the Hardeman glyphosate-based herbicide trial before Judge Vince Chhabria of the U.S. District Court for the Northern District of California. This is the first case in the glyphosate federal multi-district litigation (MDL) to go to trial. “While we have great sympathy for Mr. Hardeman, the extensive […]
Bayer provided the following response to a new meta-analysis by Zhang L, Rana I, Taioli E, Shaffer RM, Sheppard L, a copy of which has been pre-published online. This meta-analysis, which is a statistical combination of data collected by other studies, includes select data from the most recent update of the Agricultural Health Study (AHS) […]
The following is Bayer’s statement regarding an order by Judge Vince Chhabria in the District Court for the Northern District of California regarding the admissibility of certain evidence during the causation phase of the upcoming Hardeman v. Monsanto trial. “Under the reverse bifurcation process for these first trials and the Court’s evidentiary order, we continue […]
The following is Bayer’s statement regarding an order by Judge Winifred Y. Smith in the Superior Court of the State of California for the County of Alameda denying plaintiffs’ motion for consolidation. “We appreciate the court’s willingness to examine closely the possibility that the potential for bias is high in a multi-plaintiff trial. We continue […]
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.